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Abstract
In this study we investigated the additive effect of mercury on the brain mitochondrial 
dysfunction in experimental autoimmune encephalomyelitis (EAE) model. Experimental 
animals (female C57BL/6 mice) are divided into four groups (n = 8); control, Hg, EAE, 
EAE with Hg. EAE model of MS induced by injecting myelin oligodendrocyte glycoprotein 
(MOG). Neurobehavioral alterations are recorded and then mice were sacrificed at day 28 
and brain mitochondria were isolated and mitochondrial toxicity parameters including 
mitochondrial swelling, reactive oxygen species (ROS) formation, collapse of mitochondrial 
membrane potential (MMP) and cytochrome c release were measured. Our results showed 
that repeated treatment of mercury following induction of EAE in mice significantly increased 
the neurobehavioral scores, as well as mitochondrial toxicity through ROS formation, 
mitochondrial swelling, collapse of MMP and cytochrome c release. Our findings proved that 
repeated exposure with mercury accelerates progression of MS through mitochondrial damage 
related to oxidative stress and finally apoptosis.
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Introduction
Mercury is a heavy metal that has known as 
a toxicant in living organisms and exposure to 
mercury compounds continue to be prevalent 
and significant health risks to human (1). 
Approximately one million tons of metallic Hg 
has been extracted from ores during the past five 
centuries (2). Original routes of human exposure 
to Hg are environmental contaminant, industrial 
usage and health care. Multiple sclerosis is a 
chronic and progressive autoimmune disease 
in the central nervous system (CNS) of young 
adults, with over 2.5 million individuals affected 
worldwide (3). MS has almost unknown 
etiology and no effective cure at the time being. 
it`s treatment is supportive and symptomatic 
(4). Mitochondria extensive dysfunction and 
concomitant oxidative  stress  can cause  many 
neurodegenerative  diseases such as multiple 
sclerosis (5). There are many study that show 
relation between mercury exposure and MS for 
example mercury-containing amalgam may exert 
an important risk for patients with autoimmune 
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diseases (6). Mercury concentrations in the 
cerebrospinal fluid and blood serum of MS 
patients is higher than healthy individuals (7) .It 
has already been demonstrated that inhibition of 
myelin production can be resulted from  toxic 
effect of mercury on human oligodendrocytes (8).
In this study for evaluation of relationship 
progression of MS and repeated exposure of 
mercury we used EAE model to induce MS in 
C57BL/6 mice, then neurobehavioral symptoms 
observed and recorded. Finally We sacrificed 
mice at day 28 following EAE induction 
and then brain mitochondria were isolated to 
examine mitochondrial damage parameters 
such as mitochondrial swelling, ROS formation, 
collapse of MMP and cytochrome c release.
Material and Methods
Animals 
All experiments were performed on female 
C57BL/6 mice (Razi Institute, Karaj, Iran) 
weighing 20-25 g (12 weeks).The animals 
were kept under a 12 h light/dark cycle in a 
temperature controlled (22. 2 ± °C) environment 
with free access to food and water ad libitum. 
All studies and animal care procedures were 
accomplished in accordance with the local ethics 
committee for animal experimentation and in 
compliance with guidelines of Shahid Beheshti 
University of Medical Sciences. 
Induction of EAE and experimental design 
EAE model for MS was induced in mice 
with MOG35–55 peptide emulsified in complete 
Freund’s adjuvant (CFA) using Hooke kits 
(Hooke Laboratories, Lawrence, MA, USA) 
according to the manufacturer’s instruction. All 
drugs and their respective vehicles were injected 
intraperitoneally.  The intact (no EAE) group 
received CFA and pertussis toxin without MOG. 
Mercury sulfides suspended in carboxymethyl 
cellulose (CMC) then it exposed to mice oral 
daily (1 mg/Kg/day) for 7 days from the onset of 
EAE induction. (9). 
The following groups were used in this study: 
control group received CFA and pertussis toxin 
without MOG, EAE group, mercury sulfide 
group, and EAE + mercury sulfide group. 
The number of animals in each group were 
8(n=8).
Neurological assessment
Mice were daily observed to record 
behavioral and neurological signs until day 28 
after immunization.  The signs of EAE were 
scored protocol of Stromnes et al.  (10).
Mitochondrial preparation
At 28th day after induction EAE  mice were 
sacrificed and brain and spinal cord mitochondria 
were isolated using differential centrifugation 
(11). Mitochondria were prepared freshly for 
each experiment and used within 4 h of isolation. 
Determination of mitochondrial ROS level
The mitochondrial ROS measurement 
was performed using the fluorescent probe 
DCFH-DA. The fluorescence  intensity of DCF 
was measured using Shimadzu RF-5000U 
fluorescence spectrophotometer at an excitation 
wavelength of 488 nm and emission wavelength 
of 527 nm (12, 13).
Determination of the MMP
Mitochondrial uptake of the cationic 
fluorescent dye, rhodamine123, has been used 
for the estimation of mitochondrial membrane 
potential. The mitochondrial fractions (0.5 
mg protein/mL) were incubated with 10 µM 
of rhodamine 123 in MMP assay buffer.  The 
fluorescence was monitored using Shimadzu 
RF-5000U fluorescence spectrophotometer at 
the excitation and emission wavelength of 490 
nm and 535 nm, respectively (14, 15) .
Determination of mitochondrial swelling
Briefly, isolated mitochondria were suspended 
in swelling buffer (70 mM sucrose, 230 mM 
mannitol, 3 mM HEPES, 2 mM tris phosphate, 
5 mM succinate and 1 µM of rotenone). The 
absorbance was measured at 549 nm at 15 min 
time intervals with an ELISA reader (Tecan, 
Rainbow Thermo and Austria) (13, 16). 
Cytochrome c release assay
The concentration of cytochrome c was 
determined through using the Quantikine 
Rat/Mouse Cytochrome c Immunoassay kit 
provided by R&D Systems, Inc. (Minneapolis, 
Minn.) according to manufacturer’s instruction 
(15). 
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Statistical analysis
The results are expressed as mean ± 
SEM and were analyzed using Graph Pad 
Prism (version 5, Graph pad Software Inc.). 
A one-way or two-way analysis of variance 
(ANOVA) followed by Bonferroni’s tests 
were used for multiple comparison. For 
all statistical analyses, p<0.05 was considered 
significant.
Results
 EAE scoring 
As shown in Figure 1 behavioral and 
neurological signs were increased in EAE 
induced group which repeatedly received Hg. 
In the Hg2+treated group, there were also some 
behavioral and neurological signs.
Measurement of ROS generation
As shown in Figure 2. ROS significantly 
(P<0.05) increased in the brain mitochondria 
isolated from (EAE + Hg2+) group compared 
with EAE group. ROS were also significantly 
(P<0.05) increased in EAE group compared with 
control group.
Determination of mitochondrial membrane 
potential
As shown in Figure 3. MMP significantly 
decreased in the brain mitochondria isolated 
from EAE + Hg group compared with EAE 
group.
Measurement of mitochondrial swelling 
As shown in Figure 4. collapse of optical 
absorbance at 540 nm which is consistent with 
mitochondrial swelling, was assayed. Our results 
showed that of repeated administration of mercuric 
sulfide significantly enhanced swelling in the 
brain mitochondria isolated from (EAE + Hg).
Cytochrome c release 
As shown in Figure 5. there is significant 
enhancement in the release of cytochrome c 
from brain mitochondria in the (EAE + Hg) 
group compared with EAE group.
Discussion
Using EAE scoring test we proved that, 
mercury causes behavioral, neuromuscular, 
sensorimotor disturbances in EAE + Hg treated 
mice compared to Hg group (Figure 1). Our 
results showed that in Hg accelerated behavioral 
dysfunction in EAE model. Moreover there are 
many previous studies that indicate relationship 
between MS and mercury. Mercury is a heavy 
Figure 1.  Behavioral and neurological signs in mice experimental groups. Values were presented as score of signs as described in 
materials and methods (n = 8). ** represents P < 0.01 significant difference, *** represents P < 0.001 significant difference, compared 
to EAE induced mice group.
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Figure 2.  ROS formation. Exposure to mercury (Hg) intensified ROS formation in EAE + Hg group compared to EAE group. Values 
have been presented as percent ROS formation (n = 8). *** represents significant difference between control and EAE groups, also $$$ 
represents significant difference (P < 0.001) between EAE and EAE+Hg2+ groups.
Figure 3.    Decline of MMP. Decline of MMP significantly decreased in EAE + Hg group compared to EAE group. Values expressed 
as percent of MMP collapse (n = 8). *** represents significant difference between control and EAE groups, also $$$ represents significant 
difference (P < 0.001) between EAE and EAE + Hg groups.
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metal that exerts acute and chronic toxic effects 
on the human body including the nervous and 
immune systems (17). One of the main pathways 
of mercury toxicity is damage to mitochondrial 
function (18). Malfunction of mitochondria has 
been associated to neurodegenerative diseases 
(19). The functionality of mitochondrial 
preparations is very useful in the study of the 
processes underlying pathologies of these 
diseases. It has already proven that use of isolated 
mitochondria is a very powerful tool in the 
study of pathologies of many neurodegenerative 
(20). Results of ROS measurement in isolated 
mitochondria showed that ROS formation was 
Figure 4.  Mitochondrial swelling. Hg enhanced mitochondrial swelling in EAE + Hg group. Values have been presented as decreasing 
absorbance at 450 nm (n = 8). *** represents significant difference between control and EAE groups, also $$$ represents significant 
difference (P < 0.001) between EAE and EAE + Hg groups.
Figure 5.  Cytochrome c release. In EAE + Hg and EAE groups cytochrome c released. Values have been presented as mean ± SD 
(n = 8). *** represents significant difference (P < 0. 001) compared to EAE induced group. Also $$$ represents significant difference 
(P < 0. 001) between EAE + Hg and EAE groups.
 Kahrizi F et al. / IJPR (2016), 15 (4): 834-841
840
significantly increased in EAE + Hg+2 group 
(Figure 2). Following the rise of reactive oxygen 
species formation and consecutive oxidative 
damage to mitochondria, mitochondrial 
functions are impaired. Our findings regarding 
mitochondrial membrane potential collapse 
(Figure 3.) and mitochondrial swelling (Figure 
4.) in EAE + Hg group proved this hypothesis. 
Previous studies with mercury have also shown 
increased damage through ROS formation. 
Our results suggest in this animal model, 
substantial ROS produced by mercury increases 
and accelerates neural damage compared to 
EAE group. The increased mitochondrial 
ROS formation can cause oxidation of a lipid 
membrane which consequently results in 
disruption of the mitochondrial membrane and 
subsequently the collapse of mitochondrial 
membrane potential (MMP) and cytochrome c 
release. (21). A number of studies have reported 
mitochondrial defects in MS. We also showed 
that in EAE model mitochondrial damages 
increased which with repeated exposure with 
mercury these damage significantly increased.  
Our results provided evidence that 
cumulative mitochondrial damages result in 
mercury accelerates progression MS through 
mitochondrial ROS formation that lead to 
collapse MMP, mitochondrial swelling  and 
finally initiation of apoptosis signaling through 
mitochondrial pathway. To our knowledge this 
the first report that provides relationship between 
mitochondrial events and progression of MS 
through apoptosis by mercury in brain.
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